In Vitro Activities of Telavancin and Six Comparator Agents against Anaerobic Bacterial Isolates

In Vitro Activities of Telavancin and Six Comparator Agents against Anaerobic Bacterial Isolates In Vitro Activity of Telavancin against Resistant Gram-Positive Bacteria In Vitro Activity of Telavancin against Gram-Positive Clinical Isolates Recently Obtained in Europe Comparative Surveillance Study of Telavancin Activity against Recently Collected Gram-Positive Clinical Isolates from across the United States In Vitro Activity of Telavancin against a Contemporary Worldwide Collection of Staphylococcus aureus Isolates In Vitro Activities of Telavancin and Vancomycin against Biofilm-Producing Staphylococcus aureus , S . epidermidis , and Enterococcus faecalis Strains Comparative Efficacies of Telavancin and Vancomycin in Preventing Device-Associated Colonization and Infection by Staphylococcus aureus in Rabbits In Vitro Evaluation of the Activities of Telavancin, Cefazolin, and Vancomycin against Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus in Peritoneal Dialysate Activity of Telavancin against Staphylococcus aureus Strains with Various Vancomycin Susceptibilities in an In Vitro Pharmacokinetic/Pharmacodynamic Model with Simulated Endocardial Vegetations Comparative Efficacies of Human Simulated Exposures of Telavancin and Vancomycin against Methicillin-Resistant Staphylococcus aureus with a Range of Vancomycin MICs in a Murine Pneumonia Model